Related Experiment Video
Updated: Sep 20, 2025
07:34
The Power of Simplicity: Sea Urchin Embryos as in Vivo Developmental Models for Studying Complex Cell-to-cell Signaling Network Interactions
Published on: February 16, 2017
8.1K
Foxf2 represses bone formation via Wnt2b/β-catenin signaling
Tomoyuki Tanaka1, Akira Takahashi1, Yutaka Kobayashi1
1Department of Orthopaedics, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan.
Experimental & Molecular Medicine
|June 6, 2022
Summary
The forkhead transcription factor Foxf2 regulates bone formation. Inhibiting Foxf2 promotes osteoblastic differentiation, offering potential treatments for osteoporosis and fractures.
Area of Science:
- Molecular Biology
- Cell Biology
- Bone Biology
Background:
- Mesenchymal stem cell (MSC) differentiation into osteoblasts is vital for bone health.
- The precise regulatory mechanisms governing osteoblast differentiation remain incompletely understood, posing challenges for treating osteoporosis and fractures.
Purpose of the Study:
- To identify key regulators of MSC osteoblastic differentiation.
- To investigate the role of the transcription factor Foxf2 in bone formation and its therapeutic potential.
Main Methods:
- Comprehensive gene expression analysis during MSC osteoblastic differentiation.
- Overexpression and knockdown studies of Foxf2 in MSCs and mouse models.
- RNA-sequencing (RNA-seq) and molecular pathway analysis.
- Assessment of bone mass and regeneration in vivo.
- Correlation analysis of FOXF2 expression with bone mineral density in postmenopausal women.
Main Results:
- Foxf2 expression levels increase transiently during MSC osteoblastic differentiation.
- Overexpression of Foxf2 inhibits osteoblastic differentiation, while Foxf2 knockdown promotes it.
- Osteoprogenitor-specific Foxf2 knockout mice exhibit increased bone formation and high bone mass.
- Foxf2 regulates bone formation via the Wnt2b pathway.
- Foxf2 knockdown enhances bone regeneration in mouse femurs.
- Reduced FOXF2 expression correlates with lower hip bone mineral density in postmenopausal women.
- Inhibition of FOXF2 promotes osteoblastic differentiation in human MSCs.
Conclusions:
- Foxf2 is a critical negative regulator of mesenchymal stem cell differentiation into osteoblasts.
- Targeting Foxf2 offers a promising therapeutic strategy for enhancing bone formation in conditions like osteoporosis and fracture nonunion.
Related Concept Videos
02:54Canonical Wnt Signaling Pathway
9.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
01:24Bone Formation by Endochondral Ossification
5.8K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
5.8K
01:41Non-Canonical Wnt Signaling Pathways
7.5K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.5K
01:29Bone Formation by Intramembranous Ossification
7.8K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
7.8K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
01:40Bone Remodeling
38.6K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.6K